Brain Glucose Metabolism During Transcranial Direct Current Stimulation
Depression

About this trial
This is an interventional basic science trial for Depression focused on measuring Transcranial direct current stimulation, Positron emission tomography
Eligibility Criteria
Inclusion Criteria:
Healthy controls:
- Aged 18 to 55 years Somatic and psychiatric health based on medical history, physical examination, ECG, laboratory screening, SCID-I and II Willingness and competence to complete the informed consent process
Depressed Patients:
Current major depressive episode during unipolar major depression (MD) according to SCID-I (with HAMD>17) No other concomitant axis-I disease apart from anxiety disorder, which must be secondary to MD Standard antidepressant medication stable during the last 4 weeks
Exclusion Criteria:
- Concomitant major medical or neurological illness, including history of seizures Any current substance abuse disorder according to DSM-V (urinary test and history) including current sedative usage in MDD patients ECT, TMS or NMDA-antagonists (ketamine) during the past 6 months. Current augmentation with anti-epileptics, or other drugs affecting seizure threshold Failure to comply with the study protocol or follow the instructions of the investigators Pregnancy Participants with previous total radiation exposure dose of 30mSv over the last 10 years (according to legislation on radiation protection).
Left-handedness
Sites / Locations
- Department of Psychiatry and Psychotherapy, Medical University of Vienna
Arms of the Study
Arm 1
Arm 2
Experimental
Sham Comparator
active transcranial direct current stimulation
Sham tDCS
Stimulation at three different intensities during FDG-PET scan
Comparator to active arm